Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prasant Chandran

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the ratPrisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Journal of Medicinal Chemistry|March 4, 2008
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activityJennifer M Frost, Michael J Dart, Karin R Tietje, et al.
Neuroimage|September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritisJaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain managementDerek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Biochemical Pharmacology|May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in ratsChang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
Journal of Medicinal Chemistry|November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesiaHuaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imagingBetty B Yao, Gin Hsieh, Anthony V Daza, et al.
Pain|January 13, 2009
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermiaPrisca Honore, Prasant Chandran, Gricelda Hernandez, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the ratPrisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Journal of Medicinal Chemistry|March 4, 2008
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activityJennifer M Frost, Michael J Dart, Karin R Tietje, et al.
Neuroimage|September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritisJaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain managementDerek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Biochemical Pharmacology|May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in ratsChang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
Journal of Medicinal Chemistry|November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesiaHuaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imagingBetty B Yao, Gin Hsieh, Anthony V Daza, et al.
Pain|January 13, 2009
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermiaPrisca Honore, Prasant Chandran, Gricelda Hernandez, et al.
Pageof 2